| Bioactivity | Anticancer agent 9, a glycine derivative, is an anticancer agent. Anticancer agent 9 can inhibit tumor cells viability of myelogenous leukemia and human prostate cancer[1]. | ||||||||||||
| Invitro | Anticancer agent 9 (compound 24) (96 h) inhibits the cell growth, with IC50s of 0.1 μM and 0.1 μM for K562 and DU145 cells, respectively[1]. | ||||||||||||
| Name | Anticancer agent 9 | ||||||||||||
| CAS | 592542-61-5 | ||||||||||||
| Formula | C22H27NO8S | ||||||||||||
| Molar Mass | 465.52 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Pallela VR, et, al. Hydrothiolation of benzyl mercaptan to arylacetylene: application to the synthesis of (E) and (Z)-isomers of ON 01910•Na (Rigosertib®), a phase III clinical stage anti-cancer agent. Org Biomol Chem. 2013 Mar 28;11(12):1964-77. |
Anticancer agent 9
CAS: 592542-61-5 F: C22H27NO8S W: 465.52
Anticancer agent 9, a glycine derivative, is an anticancer agent. Anticancer agent 9 can inhibit tumor cells viability o
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.